You’ve done the research. Your doctor mentioned tirzepatide, or maybe a friend lost 40 pounds on it and you want in. The problem is not finding a provider. It’s sorting the 30-plus telehealth sites competing for your credit card from the ones that actually ship medication from a legitimate pharmacy, have a real physician in the loop, and won’t quietly raise prices after month two.
These ten options keep showing up in forum threads, Reddit weight-loss communities, and insurance comparison discussions. Here’s what makes each one distinct.
1. Mochi Health
Mochi puts board-certified obesity-medicine clinicians front and center, which most telehealth brands quietly skip. Compounded tirzepatide runs around $199 per month, compounded semaglutide around $99. The monitoring is more hands-on than most cash-pay services at this price. Patients in online communities specifically mention feeling like they’re actually talking to someone who knows metabolic medicine rather than just clicking through a prescription queue.
2. HealthRX
The clearest use case for HealthRX is someone who wants low cash pricing, fast access, and wants to know exactly where their medication comes from. Compounded tirzepatide starts at $149 per month. Compounded semaglutide starts at $99. A US board-certified physician reviews your intake within roughly 24 hours. Next-day shipping is included at no extra charge, with delivery available in every state.
The pharmacy is Manifest Pharmacy in Greer, South Carolina, a 503A facility operating under USP-797 standards with lot-to-door tracking. LegitScript certified (certificate 50087439). That’s a named, verifiable compounding pharmacy rather than a vague “licensed partner.”
Worth saying plainly: compounded medications are not FDA-approved finished drug products, so you are not getting branded Mounjaro or Zepbound. The SURMOUNT-1 trial showed tirzepatide producing roughly 21% body weight reduction at 72 weeks. That figure comes from the clinical trial, not HealthRX’s own outcomes data.
3. FormBlends
FormBlends is the pick for someone who wants published analytical testing on their compounded GLP-1, specifically HPLC purity percentages, mass spec identity confirmation, and endotoxin and sterility data, with named numbers rather than a general “quality assurance” statement. Most telehealth-only GLP-1 brands do not publish that level of batch documentation.
Per-vial pricing lands near $299 for compounded semaglutide and $349 for tirzepatide. Notably more expensive than HealthRX’s entry pricing. Ships to 47 states, not all 50. The same clinician model also covers a wide peptide catalog including recovery, longevity, and cognitive-focused compounds, which makes it a reasonable single-provider option for someone already interested in that category. Physician oversight applies throughout.
4. Hims & Hers
Brand recognition is real here. Following a settlement with Novo Nordisk reported in March 2026, Hims & Hers moved away from compounded semaglutide and toward branded medications. Injectable Wegovy runs around $299 per month through their platform, oral semaglutide around $249, and Zepbound around $399. With insurance plus a savings card, some patients report hitting near-zero monthly cost. If you have insurance that covers GLP-1s and want a polished app experience, this is a reasonable starting point.
5. Ro Body
Ro charges a membership fee, roughly $39 for the first month and $74 to $149 monthly after that, with medications billed separately. Their prior-authorization team actively works insurance approvals for branded GLP-1s, which is a concrete service most budget telehealth platforms skip entirely. If getting Zepbound or Wegovy covered by insurance is your goal rather than cash-pay compounded, Ro is one of the more patient-friendly options at this.
6. PlushCare
PlushCare’s membership sits at $19.99 per month. It functions more like a traditional telehealth primary care service that also prescribes weight-loss medications, meaning you can get same-day visits and handle other health issues through one subscription. Branded meds with insurance. Not the cheapest cash-pay option, but genuinely useful if you want ongoing primary care alongside your GLP-1 prescription.
7. Henry Meds
Fast. Cash-pay compounded tirzepatide and semaglutide, with shipping quoted at 24 to 72 hours after approval. Pricing starts around $179 to $249 for month one. Lighter on the clinical monitoring side compared to Mochi, which is the honest tradeoff for the speed and lower price.
8. Found
Found charges around $99 per month for platform access, with medications billed on top. The coaching layer is more structured than most, covering behavioral patterns and food habits alongside the medication side. Good fit if accountability tools matter as much as the prescription itself.
9. Form Health
Premium tier. Around $299 per month, plus labs and medications. You get an MD alongside a registered dietitian working as a pair. The monitoring is close to what you’d expect from a brick-and-mortar obesity clinic. Expensive, but the clinical depth is real.
10. WeightWatchers Clinic
WeightWatchers added a clinical GLP-1 program at around $74 per month for the program fee, with medications separate. If you already use WW’s tracking tools and want to add a prescription component without switching platforms entirely, it fits without much friction.
Pricing on compounded medications can shift, and the regulatory environment around compounding pharmacies remains active following FDA warning letters to over 30 telehealth and compounding firms in early 2026. Confirm current availability and pricing directly with any provider before committing.
Common Questions
Is compounded tirzepatide the same molecule as branded Mounjaro or Zepbound?
The active ingredient is tirzepatide in both cases, but compounded versions are not FDA-approved finished drug products. They are mixed at a 503A or 503B pharmacy to a physician’s specification. Purity and sterility depend entirely on that pharmacy’s standards, which is why asking for batch testing documentation, as FormBlends publishes, matters.
Why does HealthRX cost so much less than Hims & Hers or Form Health for tirzepatide?
HealthRX dispenses compounded tirzepatide starting at $149 per month, while Hims & Hers lists branded Zepbound at around $399. The difference is the product itself. Compounded medications bypass the branded drug’s list price entirely. The tradeoff is that compounded versions carry no FDA-approved drug label, and quality assurance rests with the compounding pharmacy rather than the original manufacturer.
How do I know whether a telehealth clinic’s compounding pharmacy is actually legitimate?
Look for three things: a named pharmacy (not just “licensed partner”), a 503A or 503B designation from the FDA, and independent certification such as LegitScript. HealthRX names Manifest Pharmacy in Greer, South Carolina, with its LegitScript certificate number (50087439) publicly listed. That level of transparency is not universal across the platforms on this list.
Which of these clinics makes the most sense if my insurance might cover a branded GLP-1?
Ro Body and Hims & Hers are the strongest fits here. Ro specifically runs a prior-authorization service for branded medications, which takes real administrative effort most budget platforms skip. Hims & Hers shifted toward branded drugs after its March 2026 settlement and lists Wegovy and Zepbound directly. PlushCare also handles insurance but functions more as a general primary care service.
What happened to compounded semaglutide and tirzepatide availability after the FDA warning letters in early 2026?
The FDA sent warning letters to more than 30 telehealth and compounding firms, targeting platforms it found were not meeting compounding standards or were marketing improperly. Some providers stopped offering compounded GLP-1s or shifted to branded products, as Hims & Hers did with semaglutide. Availability is still shifting, so confirming current status directly with any clinic before signing up is genuinely necessary, not just a legal disclaimer.
Sources
- FDA SURMOUNT-1 trial publication, tirzepatide Phase 3 data (NEJM, 2022)
- FDA STEP 1 trial publication, semaglutide Phase 3 data (NEJM, 2021)
- FDA compounding pharmacy 503A regulatory framework, FDA.gov
- LegitScript pharmacy certification database, LegitScript.com
- Hims & Hers / Novo Nordisk settlement coverage, Reuters and STAT News, March 2026
- Lilly orforglipron / LillyDirect pricing, Lilly press release, April 2026
